PTP Accounts Production v24.3.2.46 05681316 Board of Directors 1.6.23 31.5.24 31.5.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh056813162023-05-31056813162024-05-31056813162023-06-012024-05-31056813162022-05-31056813162022-06-012023-05-31056813162023-05-3105681316ns15:EnglandWales2023-06-012024-05-3105681316ns14:PoundSterling2023-06-012024-05-3105681316ns10:Director12023-06-012024-05-3105681316ns10:PrivateLimitedCompanyLtd2023-06-012024-05-3105681316ns10:SmallEntities2023-06-012024-05-3105681316ns10:AuditExempt-NoAccountantsReport2023-06-012024-05-3105681316ns10:SmallCompaniesRegimeForDirectorsReport2023-06-012024-05-3105681316ns10:SmallCompaniesRegimeForAccounts2023-06-012024-05-3105681316ns10:FullAccounts2023-06-012024-05-3105681316ns10:Director22023-06-012024-05-3105681316ns10:RegisteredOffice2023-06-012024-05-3105681316ns5:CurrentFinancialInstruments2024-05-3105681316ns5:CurrentFinancialInstruments2023-05-3105681316ns5:Non-currentFinancialInstruments2024-05-3105681316ns5:Non-currentFinancialInstruments2023-05-3105681316ns5:ShareCapital2024-05-3105681316ns5:ShareCapital2023-05-3105681316ns5:RetainedEarningsAccumulatedLosses2024-05-3105681316ns5:RetainedEarningsAccumulatedLosses2023-05-3105681316ns5:PlantMachinery2023-06-012024-05-3105681316ns5:FurnitureFittings2023-06-012024-05-3105681316ns5:PlantMachinery2023-05-3105681316ns5:FurnitureFittings2023-05-3105681316ns5:PlantMachinery2024-05-3105681316ns5:FurnitureFittings2024-05-3105681316ns5:PlantMachinery2023-05-3105681316ns5:FurnitureFittings2023-05-3105681316ns5:WithinOneYearns5:CurrentFinancialInstruments2024-05-3105681316ns5:WithinOneYearns5:CurrentFinancialInstruments2023-05-3105681316ns5:Secured2024-05-3105681316ns5:Secured2023-05-3105681316ns5:DeferredTaxation2023-05-3105681316ns5:DeferredTaxation2023-06-012024-05-3105681316ns5:DeferredTaxation2024-05-3105681316ns5:RetainedEarningsAccumulatedLosses2023-05-3105681316ns5:RetainedEarningsAccumulatedLosses2023-06-012024-05-31
REGISTERED NUMBER: 05681316 (England and Wales)















Financial Statements for the Year Ended 31 May 2024

for

Pharmaunison Limited

Pharmaunison Limited (Registered number: 05681316)






Contents of the Financial Statements
for the Year Ended 31 May 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Pharmaunison Limited

Company Information
for the Year Ended 31 May 2024







DIRECTORS: R S Nagra
Mrs A Nagra





REGISTERED OFFICE: 30 Great Bridge
Tipton
West Midlands
DY4 7EW





REGISTERED NUMBER: 05681316 (England and Wales)





ACCOUNTANTS: Aggarwal & Co
Chartered Certified Accountants
471 Green Lane
Coventry
West Midlands
CV3 6EL

Pharmaunison Limited (Registered number: 05681316)

Balance Sheet
31 May 2024

31.5.24 31.5.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 9,168 12,223

CURRENT ASSETS
Stocks 20,871 23,100
Debtors 5 501,245 535,350
Cash at bank and in hand 111,708 91,029
633,824 649,479
CREDITORS
Amounts falling due within one year 6 161,400 155,424
NET CURRENT ASSETS 472,424 494,055
TOTAL ASSETS LESS CURRENT
LIABILITIES

481,592

506,278

CREDITORS
Amounts falling due after more than one
year

7

(242,326

)

(274,035

)

PROVISIONS FOR LIABILITIES 9 (2,292 ) (3,056 )
NET ASSETS 236,974 229,187

CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings 10 236,973 229,186
SHAREHOLDERS' FUNDS 236,974 229,187

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Pharmaunison Limited (Registered number: 05681316)

Balance Sheet - continued
31 May 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 4 February 2025 and were signed on its behalf by:





R S Nagra - Director


Pharmaunison Limited (Registered number: 05681316)

Notes to the Financial Statements
for the Year Ended 31 May 2024

1. STATUTORY INFORMATION

Pharmaunison Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on reducing balance
Fixtures, fittings & equipment - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 7 (2023 - 4 ) .

Pharmaunison Limited (Registered number: 05681316)

Notes to the Financial Statements - continued
for the Year Ended 31 May 2024

4. TANGIBLE FIXED ASSETS
Fixtures,
Plant and fittings
machinery & equipment Totals
£    £    £   
COST
At 1 June 2023
and 31 May 2024 8,199 49,482 57,681
DEPRECIATION
At 1 June 2023 7,518 37,940 45,458
Charge for year 170 2,885 3,055
At 31 May 2024 7,688 40,825 48,513
NET BOOK VALUE
At 31 May 2024 511 8,657 9,168
At 31 May 2023 681 11,542 12,223

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.5.24 31.5.23
£    £   
Trade debtors 76,639 62,930
Amounts owed by group undertakings 407,859 456,407
Other debtors 16,747 16,013
501,245 535,350

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.5.24 31.5.23
£    £   
Bank loans and overdrafts 26,992 28,231
Trade creditors 101,310 104,746
Taxation and social security 31,204 20,674
Other creditors 1,894 1,773
161,400 155,424

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.5.24 31.5.23
£    £   
Bank loans 242,326 274,035

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal 98,623 119,419

Pharmaunison Limited (Registered number: 05681316)

Notes to the Financial Statements - continued
for the Year Ended 31 May 2024

8. SECURED DEBTS

The following secured debts are included within creditors:

31.5.24 31.5.23
£    £   
Bank loans 269,318 302,266

9. PROVISIONS FOR LIABILITIES
31.5.24 31.5.23
£    £   
Deferred tax 2,292 3,056

Deferred
tax
£   
Balance at 1 June 2023 3,056
Utilised during year (764 )
Balance at 31 May 2024 2,292

10. RESERVES
Retained
earnings
£   

At 1 June 2023 229,186
Profit for the year 82,787
Dividends (75,000 )
At 31 May 2024 236,973

11. RELATED PARTY DISCLOSURES

The company is wholly owned subsidiary of MSN Pharm Ltd. (Registered number : 08089515), a company registered in UK.

12. ULTIMATE CONTROLLING PARTY

The controlling party is Mr R S Nagra and Mrs A Nagra.